LRBA Deficiency: A Patient Guide
At a Glance
LRBA deficiency is a rare inherited immune disorder that can cause the immune system to attack the gut, blood cells, and organs while increasing infections. Genetic diagnosis supports targeted care, including abatacept, transplant evaluation, and lifelong monitoring.
LRBA deficiency is an ultra-rare genetic condition that fundamentally changes how the immune system behaves. In a healthy body, the immune system is a precisely balanced machine, capable of revving up to fight a virus and then immediately cooling down once the threat has passed. This cooling-down phase is managed by internal “brakes” that tell immune cells to stop attacking. In those with LRBA deficiency, a missing protein impairs the trafficking and recycling of a key immune brake called CTLA-4, leaving the immune system in a state of variable, uncontrolled overactivity [1][2].
Because these internal brakes are impaired, the immune system often begins to attack the body’s own healthy tissues, a process known as immune dysregulation. This overactivity most commonly manifests in three ways: severe and chronic digestive issues that resemble inflammatory bowel disease, the destruction of the body’s own blood cells, and the swelling of organs like the spleen and liver. Ironically, while the immune system is overactive in its attack on the body, it is often poorly defended against external germs, leading to a cycle of recurrent infections, particularly in the lungs and sinuses [3][4].
Receiving a genetic diagnosis is a pivotal moment because it clarifies that these diverse symptoms are not separate problems, but part of a single underlying cause. This clarity opens the door to targeted therapies, such as abatacept (an off-label medication that mimics some of the missing CTLA-4 inhibitory function), which can significantly improve daily life and stabilize symptoms. For some, a stem cell transplant may even offer the possibility of a permanent cure by providing the body with a functional immune system, though it carries substantial risks [5][6].
Living with LRBA deficiency requires a commitment to lifelong, individualized monitoring. Because the condition can quietly affect the lungs or other organs even when you feel relatively well, regular check-ups and age-appropriate clinical assessment are essential for catching changes early. While the path forward involves many specialists and careful management, the transition from “searching for answers” to “targeted treatment” provides a clearer, more hopeful framework for navigating life with this rare condition [7][8].
In this guide
6 chapters
Understanding LRBA Deficiency: An Overview
Learn what LRBA deficiency is, how inherited gene changes disrupt CTLA-4 immune brakes, why symptoms vary, and what diagnosis and long-term care may involve.
Symptoms and Emergency Warning Signs
Learn common LRBA deficiency symptoms and emergency warning signs of infection, breathing problems, bleeding, dehydration, and neurologic changes to watch for.
The Biology of LRBA: Shuttles and Brakes
Learn how LRBA deficiency disrupts CTLA-4 recycling, overactivates immune cells, and causes autoimmunity; genetic testing separates look-alike disorders.
Diagnosis and Understanding Your Lab Results
Learn how LRBA deficiency is diagnosed with genetic sequencing, parental testing, flow cytometry, CTLA-4 studies, and immune labs, including B-cell counts.
Treatment Options: Targeted Therapy and Transplant
Learn how LRBA deficiency is treated with abatacept, supportive care, or a stem cell transplant, including risks, timing, and questions for your care team.
Long-Term Management and Monitoring
Learn how LRBA deficiency is monitored over time, including lung tests, blood work, growth, cancer warning signs, treatment response, and emotional support.
Common questions in this guide
What is LRBA deficiency?
What symptoms can LRBA deficiency cause?
How can a genetic diagnosis change LRBA deficiency care?
What treatments are used for LRBA deficiency?
Can a stem cell transplant cure LRBA deficiency?
What monitoring does someone with LRBA deficiency need?
Get notified when new evidence is published on Syndromic autoimmune enteropathy due to LRBA deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
Exaggerated follicular helper T-cell responses in patients with LRBA deficiency caused by failure of CTLA4-mediated regulation.
Alroqi FJ, Charbonnier LM, Baris S, et al.
The Journal of allergy and clinical immunology 2018; (141(3)):1050-1059.e10 doi:10.1016/j.jaci.2017.05.022.
PMID: 28601686 - 2
Regulation of CTLA-4 recycling by LRBA and Rab11.
Janman D, Hinze C, Kennedy A, et al.
Immunology 2021; (164(1)):106-119 doi:10.1111/imm.13343.
PMID: 33960403 - 3
Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency: A Systematic Review.
Habibi S, Zaki-Dizaji M, Rafiemanesh H, et al.
The journal of allergy and clinical immunology. In practice 2019; (7(7)):2379-2386.e5 doi:10.1016/j.jaip.2019.04.011.
PMID: 30995531 - 4
The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency.
Gámez-Díaz L, August D, Stepensky P, et al.
The Journal of allergy and clinical immunology 2016; (137(1)):223-230 doi:10.1016/j.jaci.2015.09.025.
PMID: 26768763 - 5
Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency.
Kiykim A, Ogulur I, Dursun E, et al.
The journal of allergy and clinical immunology. In practice 2019; (7(8)):2790-2800.e15 doi:10.1016/j.jaip.2019.06.011.
PMID: 31238161 - 6
Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score.
Tesch VK, Abolhassani H, Shadur B, et al.
The Journal of allergy and clinical immunology 2020; (145(5)):1452-1463 doi:10.1016/j.jaci.2019.12.896.
PMID: 31887391 - 7
Treatment and management of primary antibody deficiency: German interdisciplinary evidence-based consensus guideline.
Hanitsch L, Baumann U, Boztug K, et al.
European journal of immunology 2020; (50(10)):1432-1446 doi:10.1002/eji.202048713.
PMID: 32845010 - 8
Respiratory manifestations in LPS-responsive beige-like anchor (LRBA) protein-deficient patients.
Shamriz O, Shadur B, NaserEddin A, et al.
European journal of pediatrics 2018; (177(8)):1163-1172 doi:10.1007/s00431-018-3171-5.
PMID: 29777306
This page is for informational purposes only and does not constitute medical advice. LRBA deficiency requires individualized monitoring, so discuss abatacept, transplant, and urgent symptoms with your specialist team.